Subcutaneous Infusion of Levodopa-Carbidopa Beneficial for Parkinson Disease

Subcutaneous infusion of ND0612 increases on time without troublesome dyskinesia among patients with Parkinson disease.

Related Keywords

Albertoj Espay , ,University Of Cincinnati ,Movement Disorders Society ,Healthday News ,Movement Disorders Society Unified Parkinson ,Disease Rating Scale ,Patients Global Impression ,Clinical Global Impression ,